BRPI0924418A2 - composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade - Google Patents

composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade

Info

Publication number
BRPI0924418A2
BRPI0924418A2 BRPI0924418-2A BRPI0924418A BRPI0924418A2 BR PI0924418 A2 BRPI0924418 A2 BR PI0924418A2 BR PI0924418 A BRPI0924418 A BR PI0924418A BR PI0924418 A2 BRPI0924418 A2 BR PI0924418A2
Authority
BR
Brazil
Prior art keywords
obesity
treatment
prevention
present
gastrointestinal tract
Prior art date
Application number
BRPI0924418-2A
Other languages
English (en)
Korean (ko)
Inventor
Jin Kim Hyeon
Tshool Hong Seong
Original Assignee
Jinis Biopharmaceuticals Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinis Biopharmaceuticals Co. filed Critical Jinis Biopharmaceuticals Co.
Publication of BRPI0924418A2 publication Critical patent/BRPI0924418A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
BRPI0924418-2A 2009-03-10 2009-06-05 composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade BRPI0924418A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2009-0020474 2009-03-10
KR20090020474 2009-03-10
PCT/KR2009/003036 WO2010104242A1 (ko) 2009-03-10 2009-06-05 미생물을 이용한 비만 및 비만으로 야기된 대사성 질환의 예방과 치료

Publications (1)

Publication Number Publication Date
BRPI0924418A2 true BRPI0924418A2 (pt) 2018-10-16

Family

ID=42728512

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924418-2A BRPI0924418A2 (pt) 2009-03-10 2009-06-05 composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade

Country Status (9)

Country Link
US (1) US8986675B2 (pt)
EP (1) EP2407170B1 (pt)
JP (1) JP5665196B2 (pt)
KR (1) KR101292714B1 (pt)
CN (1) CN102438638B (pt)
BR (1) BRPI0924418A2 (pt)
CA (1) CA2755140A1 (pt)
MX (1) MX2011009508A (pt)
WO (1) WO2010104242A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6453534B2 (ja) * 2012-09-28 2019-01-16 小林製薬株式会社 脂質代謝促進剤
WO2015003001A1 (en) * 2013-07-01 2015-01-08 The Washington University Methods for identifying supplements that increase gut colonization by an isolated bacterial species, and compositions derived therefrom
US10920283B2 (en) 2013-11-01 2021-02-16 Washington University Methods to establish and restore normal gut microbiota function of subject in need thereof
KR102125548B1 (ko) * 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
KR102271821B1 (ko) * 2020-12-18 2021-07-01 주식회사 엔테로바이옴 오를리스타트 및 아커만시아 뮤시니필라 eb-amdk19 균주를 포함하는 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696537B2 (ja) * 1986-05-02 1994-11-30 雪印乳業株式会社 血清コレステロ−ル上昇抑制剤
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
KR20040027180A (ko) 2002-09-27 2004-04-01 (주)바이오니아 비만 또는 당뇨병의 예방 및 치료 효과를 갖는 유산균발효 유제품 및 그 제조방법
KR100543114B1 (ko) * 2003-09-15 2006-01-20 주식회사한국야쿠르트 바실러스 서브틸리스 케이와이 912
KR20050059860A (ko) * 2003-12-15 2005-06-21 학교법인 경영교육재단 비만 예방 및 치료용 조성물 및 이의 용도
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
CN101410128A (zh) * 2006-01-27 2009-04-15 丹尼斯科公司 益生微生物用于治疗和预防肥胖及相关病症的用途
KR100851586B1 (ko) * 2006-08-18 2008-08-12 이우정 락토바실러스를 유효성분으로 포함하는 비만 억제용 조성물
JP2008214253A (ja) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 内臓脂肪減少剤
US20100203026A1 (en) * 2007-07-25 2010-08-12 Campina Nederland Holding B.V. Probiotics for inducing satiety and/or satiation

Also Published As

Publication number Publication date
EP2407170A4 (en) 2012-11-21
CN102438638A (zh) 2012-05-02
US8986675B2 (en) 2015-03-24
KR20120022764A (ko) 2012-03-12
CN102438638B (zh) 2013-12-18
MX2011009508A (es) 2011-10-24
CA2755140A1 (en) 2010-09-16
JP2012520292A (ja) 2012-09-06
EP2407170A1 (en) 2012-01-18
WO2010104242A1 (ko) 2010-09-16
KR101292714B1 (ko) 2013-08-05
JP5665196B2 (ja) 2015-02-04
US20120121753A1 (en) 2012-05-17
EP2407170B1 (en) 2015-03-25

Similar Documents

Publication Publication Date Title
WO2010081126A3 (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
BR112012016982B8 (pt) bactéria de ácido lático recombinante de grau alimentício e composição terapêutica
WO2019066577A3 (ko) 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물
BRPI0924418A2 (pt) composições e métodos para a prevenção e o tratamento de obesidade e síndrome metabólica relacionada à obesidade
MX2014005433A (es) Métodos y composiciones para modular bacterias gastrointestinales para promover la salud.
WO2011160062A3 (en) Compositions and methods for treating inflammatory conditions
BR112012011478A2 (pt) composições fosfolipídicas terapêuticas concentradas.
WO2013103919A3 (en) Compositions and methods for treating metabolic disorders
WO2012036433A3 (ko) miRNA를 타겟으로 한 신경퇴행성 질환 치료
NZ757815A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
JP2019500056A5 (pt)
EA201391823A1 (ru) Высушенные распылением штаммы/клетки лактобактерий и их применение против helicobacter pylori
BR112017013465A2 (pt) derivado de biarila, e, composição farmacêutica.
RU2018121036A (ru) Комбинированная пре- и пробиотическая композиция
WO2010081079A3 (en) Composition and method for treatment of diabetes
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
WO2018093238A3 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
BR112013028709A2 (pt) cepas bacterianas capazes de metabolizar oxalatos
BR112012028893A2 (pt) composições imunoestimuladoras e de vacina
WO2011038014A3 (en) Composition and method for treatment of diabetes
EP4219714A3 (en) Rna interference mediated inhibition of tmprss6
Zhu et al. Modulation of lipid metabolism and colonic microbial diversity of high-fat-diet C57BL/6 mice by inulin with different chain lengths
ATE521358T1 (de) Vorbeugender und/oder therapeutischer wirkstoff zur behandlung einer funktionellen gastrointestinalen erkrankung
RU2016143195A (ru) Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза
WO2011087835A3 (en) Novel compositions and methods for treating inflammatory bowel disease and airway inflammation

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]